The private equity business of Goldman Sachs Asset Management and Charlesbank Capital Partners entered into a definitive agreement to acquire majority ownership of MDVIP from Leonard Green & Partners and Summit Partners.
HCAP Partners exited its investment in 83bar, a specialist in patient journey management for both clinical trials and commercial clients across the pharmaceutical, medical device and diagnostic industries.
Northleaf Capital Partners appointed Chris O’Connor managing director of business development for Australia and New Zealand. O’Connor will lead business development and investor relations activities and further develop relationships with institutional investors, consultants and advisors in the region.
Newcleus, a provider of employer-owned life insurance and annuity products, completed a strategic transaction with the Waterfall Sentinel Fund, a private equity vehicle managed by Waterfall Asset Management.
Hercules Capital, a specialty financing provider to venture, growth and established stage companies backed by venture capital and select private equity firms, has originated more than $1 billion year-to-date in annual total debt and equity commitments for the fourth consecutive year.
Greg Carpenter, executive vice president and managing director of Alterna Capital Solutions, joined the newly formed advisory board for a private equity fund from Alterna Equity Partners, an affiliate of Alterna Capital Solutions.
H.I.G. Capital, a global alternative investment firm with $45 billion of equity capital under management, sold its portfolio company, US Medical Supply, to Advanced Diabetes Supply, a portfolio company of Court Square Capital Partners.
Alterna Capital Solutions supported a deal origination for a lower middle-market private equity fund controlled by its affiliate, Alterna Equity Partners. The fund focuses on control and non-control investments in companies with $1 million to $10 million in EBITDA.